Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-570
Published Online: 2014-08-07
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bryant, Christopher
Rawlinson, Rebecca
Massey, Andrew J
License valid from 2014-08-07
Article History
Received: 1 May 2014
Accepted: 28 July 2014
First Online: 7 August 2014